Skip to main content
. 2021 Sep 30;12:669089. doi: 10.3389/fpsyt.2021.669089

Table 6.

Adverse events or acute health complications reported throughout the study.

Adverse events, N (%): Placebo (n = 19) Intervention (n = 21) p-value
Bronchitis/cough/respiratory infection 2 (8) 4 (19) 0.45
Cold symptoms 7 (29) 9 (43) 0.70
Constipation 3 (13) 1 (5) 0.25
Diarrhea 1 (4) 4 (19) 0.19
Emesis/nausea 4 (21) 7 (33) 0.39
Fever 2 (8) 4 (19) 0.45
Rash 0 (0) 1 (5) 0.34
Other/etc. 3 (13) 4 (19) 0.77